Cigna Sees Elevated Cost Trends To Continue Into Next Year

Cigna Group (NYSE:CI) reported second-quarter 2025 revenue of $67.13 billion on Thursday, beating analyst estimates of $62.46 billion.

Sales increased 11% year over year, primarily driven by Evernorth Health Services, and include growth of existing client relationships and strong specialty pharmacy growth.

The company reported adjusted earnings of $7.20 per share, beating analysts' estimates of $7.13.

Adjusted income from operations for the second quarter of 2025 increased 1% to $1.93 billion, reflecting strong growth in Evernorth Health Services and improvement in Corporate, partially offset by expected higher stop loss medical costs in Cigna Healthcare.

Also Read: Centene, Cigna, Others Drop As Molina’s Results Rattle Sector

Evernorth Health Services, including Pharmacy Benefit and ...